These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1319697)

  • 1. Chromosome studies in systemic sclerosis with consideration of antibodies to topoisomerase I.
    Tsay GJ; Lan JL; Li SY
    Ann Rheum Dis; 1992 May; 51(5):624-6. PubMed ID: 1319697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies.
    Jabs EW; Tuck-Muller CM; Anhalt GJ; Earnshaw W; Wise RA; Wigley F
    Cytogenet Cell Genet; 1993; 63(3):169-75. PubMed ID: 8387418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical, serological and immunogenetic studies of systemic sclerosis: a French response to the paper of JP Maddison].
    Meyer O
    Rev Rhum Mal Osteoartic; 1991 May; 58(5):371-3. PubMed ID: 1647545
    [No Abstract]   [Full Text] [Related]  

  • 4. A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.
    Doran M; Wordsworth P; Bresnihan B; Fitzgerald O
    J Rheumatol; 2001 Apr; 28(4):921-2. PubMed ID: 11327280
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-topoisomerase-I and clinical findings in systemic sclerosis (scleroderma).
    Shoenfeld Y; Grunebaum E; Laufer M; Zurgil N; Bakimer R; Lunderschmidt A; Valentini G; Tirri G; Blank M
    Isr J Med Sci; 1996 Jul; 32(7):537-42. PubMed ID: 8756980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear autoantibody profile in systemic sclerosis patients who are negative for anticentromere and anti-topoisomerase I specificities.
    Caramaschi P; Tonolli E; Biasi D; Caimmi C; Pieropan S; Dal Forno I; Scambi C; Adami S
    Joint Bone Spine; 2015 May; 82(3):209-10. PubMed ID: 25543274
    [No Abstract]   [Full Text] [Related]  

  • 7. Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?
    Benyamine A; Bertin D; Heim X; Granel B; Bardin N
    Eur J Intern Med; 2017 Oct; 44():e42-e44. PubMed ID: 28781194
    [No Abstract]   [Full Text] [Related]  

  • 8. The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies.
    Hunzelmann N; Riemekasten G; Becker MO; Moinzadeh P; Kreuter A; Melchers I; Mueller-Ladner U; Meier F; Worm M; Lee H; Herrgott I; Pfeiffer C; Fierlbeck G; Henes J; Juche A; Zeidler G; Mensing H; Günther C; Sárdy M; Burkhardt H; Koehm M; Kuhr K; Krieg T; Sunderkötter C
    Br J Dermatol; 2016 Jun; 174(6):1384-7. PubMed ID: 26708835
    [No Abstract]   [Full Text] [Related]  

  • 9. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma).
    Kuwana M; Kaburaki J; Okano Y; Inoko H; Tsuji K
    J Clin Invest; 1993 Sep; 92(3):1296-301. PubMed ID: 7690776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coexistence of antitopoisomerase I and anticentromere antibodies in systemic sclerosis].
    Garrido Rasco R; Castillo Palma MJ; García Hernández FJ; Sánchez Román J
    Med Clin (Barc); 2010 Sep; 135(9):430-1. PubMed ID: 19767035
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis.
    Maul GG; Jimenez SA; Riggs E; Ziemnicka-Kotula D
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8492-6. PubMed ID: 2479024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to topoisomerase I in sera from patients with scleroderma.
    Shero JH; Bordwell B; Rothfield NF; Earnshaw WC
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():138-40. PubMed ID: 3039129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RXRB Is an MHC-Encoded Susceptibility Gene Associated with Anti-Topoisomerase I Antibody-Positive Systemic Sclerosis.
    Oka A; Asano Y; Hasegawa M; Fujimoto M; Ishikawa O; Kuwana M; Kawaguchi Y; Yamamoto T; Takahashi H; Goto D; Endo H; Jinnin M; Mano S; Hosomichi K; Mabuchi T; Ueda MT; Nakagawa S; Beck S; Bahram S; Takehara K; Sato S; Ihn H
    J Invest Dermatol; 2017 Sep; 137(9):1878-1886. PubMed ID: 28506627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis.
    Radić M; Martinović Kaliterna D; Ljutić D
    Clin Exp Rheumatol; 2006; 24(4):407-12. PubMed ID: 16956431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-topoisomerase I autoantibodies in systemic sclerosis.
    Czömpöly T; Simon D; Czirják L; Németh P
    Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microchimerism in Japanese patients with systemic sclerosis.
    Ichikawa N; Kotake S; Hakoda M; Kamatani N
    Arthritis Rheum; 2001 May; 44(5):1226-8. PubMed ID: 11352259
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
    Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
    J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome studies in scleroderma with consideration of anticentromere antibody status and assessment of possible in vitro clastogenic activity.
    Powell FC; Schroeter AL; Winkelmann RK; Dewald GW
    Acta Derm Venereol; 1986; 66(5):414-8. PubMed ID: 2431579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of anti-topoisomerase I with cancer.
    Rothfield N; Kurtzman S; Vazques-Abad D; Charron C; Daniels L; Greenberg B
    Arthritis Rheum; 1992 Jun; 35(6):724. PubMed ID: 1318051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.